Here's another take on the issue...and one that holds little promise for existing CORX shareholders: Varney sets up a new corporation and then licenses CORX IP for a pittance. He and his cronies then jump ship to Neurolixis leaving CORX with no tangible value and a new crop of "owners" with the ability to move ampakines forward.
No idea whether such a thing is happening here; however, I’ve seen this maneuver executed in two prior instances involving biotech companies. In both cases, the companies that originally owned the IP ended up filing for bankruptcy.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”